Notably, PARP4, PARP7, PARP10, PARP11, and PARP15 have been clearly implicated in tumor development and progression, functioning either as oncoproteins with prognostic relevance or, in certain contexts, as tumor-suppressive factors. The gene discussed is PARP11; the disease is neoplasm.